Cite
COMPARING SGLT2 INHIBITORS AGAINST SACUBITRIL/VALSARTAN IN HEART FAILURE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS.
MLA
Teo, Yao Neng, et al. “Comparing Sglt2 Inhibitors against Sacubitril/Valsartan in Heart Failure: A Systematic Review and Network Meta-Analysis.” Journal of the American College of Cardiology (JACC), vol. 79, no. 9, Mar. 2022, p. 3467. EBSCOhost, https://doi.org/10.1016/S0735-1097(22)04458-8.
APA
Teo, Y. N., Teo, Y. H., Syn, N. L., Yoong, C. S. Y., Cheong, A. J. Y., Wee, C. F., Lim, Y.-C., Lee, C.-H., Yeo, T. C., Chai, P., Wong, R. C.-C., Lim, W., & Sia, C. H. (2022). Comparing Sglt2 Inhibitors against Sacubitril/Valsartan in Heart Failure: A Systematic Review and Network Meta-Analysis. Journal of the American College of Cardiology (JACC), 79(9), 3467. https://doi.org/10.1016/S0735-1097(22)04458-8
Chicago
Teo, Yao Neng, Yao Hao Teo, Nicholas L. Syn, Celine Shuen Yin Yoong, Alex Jia Yang Cheong, Caitlin Fern Wee, Yoke-Ching Lim, et al. 2022. “Comparing Sglt2 Inhibitors against Sacubitril/Valsartan in Heart Failure: A Systematic Review and Network Meta-Analysis.” Journal of the American College of Cardiology (JACC) 79 (9): 3467. doi:10.1016/S0735-1097(22)04458-8.